ADD CONDITION
Uva Ursi
Last content change checked dailysee data sync status
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
- Active ingredient
- Arctostaphylos Uva-Ursi Leaf 30 [hp_C]/30 [hp_C]
- Other brand names
- Dosage form
- Pellet
- Route
- Oral
- Prescription status
- Homeopathic
- Marketed in the U.S.
- Since 1983
- Label revision date
- November 15, 2023
- Manufacturer Document
- Prescribing information, PDF file
- Active ingredient
- Arctostaphylos Uva-Ursi Leaf 30 [hp_C]/30 [hp_C]
- Other brand names
- Dosage form
- Pellet
- Route
- Oral
- Prescription status
- Homeopathic
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1983
- Label revision date
- November 15, 2023
- Manufacturer
- Boiron
- NDC root
- 0220-5162
- Manufacturer Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
You may experience abdominal cramps during urination, which can be uncomfortable. This symptom can be associated with various conditions, and it's important to consult a healthcare professional for proper evaluation and treatment. While the specific medication name and its mechanism of action are not provided, understanding your symptoms is the first step toward finding relief. If you have concerns about your health, please reach out to a medical expert for guidance.
Uses
You may be prescribed this medication to help relieve abdominal cramps that occur during urination. It's important to understand that this medication does not have any known effects that could harm a developing fetus (teratogenic effects), making it a safer option for those who are pregnant or planning to become pregnant. Always consult with your healthcare provider for personalized advice and to ensure this treatment is right for you.
Dosage and Administration
When you first notice symptoms, take 5 pellets of the medication and let them dissolve under your tongue. You should do this three times a day. Continue this routine until your symptoms improve or follow your doctor's specific instructions. This method helps ensure that the medication works effectively to relieve your discomfort.
Warnings and Precautions
If you experience symptoms that last more than three days or worsen, it’s important to stop using the medication and contact your doctor for further guidance. While there are no specific warnings or precautions listed, always stay alert to how your body responds to any treatment.
If you have any concerns or unusual reactions, don’t hesitate to reach out to your healthcare provider for advice. Your health and safety are paramount, so keeping an open line of communication with your doctor is essential.
Overdose
If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.
In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.
Storage and Handling
It's important to store this product safely by keeping it out of reach of children to prevent any accidental ingestion or misuse. Before using, make sure to check that the seal on the pellet dispenser is intact; do not use the product if the seal is broken, as this could compromise its safety and effectiveness.
When handling the product, always ensure that you are in a clean environment to maintain its integrity. Following these guidelines will help ensure that you use the product safely and effectively.
Additional Information
No further information is available.
FAQ
What are the indications for this drug?
This drug is indicated for abdominal cramps during urination.
How should I use this drug?
At the onset of symptoms, dissolve 5 pellets under your tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Are there any teratogenic effects associated with this drug?
No teratogenic effects have been mentioned for this drug.
What should I do if my symptoms persist?
Stop use and call your doctor if symptoms persist for more than 3 days or worsen.
What precautions should I take with this drug?
Keep this drug out of reach of children and do not use if the pellet dispenser seal is broken.
Packaging Info
This section summarizes the homeopathic presentations of Uva Ursi (arctostaphylos uva-ursi leaf). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Pellet | 30 [hp_C]/30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Manufacturer Insert (PDF)
This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.
Description
Description:
This product contains ARCTOSTAPHYLOS UVA-URSI LEAF as the active ingredient, with a strength of 30 hp_C in 30 hp_C. Inactive ingredients include LACTOSE, UNSPECIFIED FORM and SUCROSE. The product is characterized by a white color, round shape, and a size of 4 mm. It is packaged in a tube, with an item code of NDC: 0220-5162-41, containing 30 hp_C. The marketing start date for this product is March 3, 1983, and it is classified as an unapproved homeopathic product.
Packaging & NDC
This section summarizes the homeopathic presentations of Uva Ursi (arctostaphylos uva-ursi leaf). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Pellet | 30 [hp_C]/30 [hp_C] | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Manufacturer Insert (PDF)
This is the product document submitted by Boiron for Uva Ursi. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.